Luzia Mayr

1.3k total citations
23 papers, 610 citations indexed

About

Luzia Mayr is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Luzia Mayr has authored 23 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Virology, 15 papers in Immunology and 10 papers in Infectious Diseases. Recurrent topics in Luzia Mayr's work include HIV Research and Treatment (19 papers), Immune Cell Function and Interaction (12 papers) and HIV/AIDS Research and Interventions (8 papers). Luzia Mayr is often cited by papers focused on HIV Research and Treatment (19 papers), Immune Cell Function and Interaction (12 papers) and HIV/AIDS Research and Interventions (8 papers). Luzia Mayr collaborates with scholars based in United States, France and China. Luzia Mayr's co-authors include Milka Sarris, Kristian G. Andersen, Felix Randow, Alexander G. Betz, Christiane Moog, Bin Su, Susan Zolla‐Pazner, Xiang‐Peng Kong, Sandra Cohen and Brett Spurrier and has published in prestigious journals such as Immunity, The Journal of Immunology and PLoS ONE.

In The Last Decade

Luzia Mayr

23 papers receiving 607 citations

Peers

Countries citing papers authored by Luzia Mayr

Since Specialization

Citations

This map shows the geographic impact of Luzia Mayr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luzia Mayr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luzia Mayr more than expected).

Fields of papers citing papers by Luzia Mayr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luzia Mayr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luzia Mayr. The network helps show where Luzia Mayr may publish in the future.

Co-authorship network of co-authors of Luzia Mayr

This figure shows the co-authorship network connecting the top 25 collaborators of Luzia Mayr. A scholar is included among the top collaborators of Luzia Mayr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luzia Mayr. Luzia Mayr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Particulate antigens administrated by intranasal and intravaginal routes in a prime-boost strategy improve HIV-specific TFH generation, high-quality antibodies and long-lasting mucosal immunity 2023 ·European Journal of Pharmaceutics and Biopharmaceutics ·Thomas Vazquez, (unknown), Fabien Pitoiset, Béatrice Levacher, J. Vigneron, Luzia Mayr, (unknown), Benjamin Bonnet, Christiane Moog, David Klatzmann, Bertrand Bellier	2
2	A FcɣRIIa polymorphism has a HLA-B57 and HLA-B27 independent effect on HIV disease outcome 2020 ·Genes and Immunity ·Raphaël Carapito, Luzia Mayr, Anne Molitor, (unknown), Sylvie Schmidt, (unknown), Marialuisa Partisani, David Rey, Olivier Lambotte, Seiamak Bahram, Christiane Moog	6
3	Anti-V2 antibody deficiency in individuals infected with HIV-1 in Cameroon 2019 ·Virology ·Lily Liu, Liuzhe Li, Aubin Nanfack, Luzia Mayr, Sonal Soni, (unknown), Lucy Agyingi, Xiaohong Wang, Michael Tuen, Yongzhao Shao, Maxim Totrov, Susan Zolla‐Pazner, (unknown), Ralf Duerr, Miroslaw K. Górny	7
4	HIV transmission from infected CD4+ T cells to allogenic T and dendritic cells is inhibited by broadly neutralizing antibodies 2018 ·AIDS ·(unknown), Bin Su, Luzia Mayr, Jéromine Klingler, Thomas Decoville, Sylvie Schmidt, Géraldine Laumond, Nathalie Salomé, Seiamak Bahram, Christiane Moog	1
5	Contrasting antibody responses to intrasubtype superinfection with CRF02_AG 2017 ·PLoS ONE ·(unknown), Luzia Mayr, Aubin Nanfack, (unknown), Michael Tuen, Ruimin Pan, Xunqing Jiang, Xiang‐Peng Kong, Allison Kirkpatrick, Daniel Bruno, Craig Martens, (unknown), Stephen F. Porcella, Andrew D. Redd, Thomas C. Quinn, Phillipe N. Nyambi, Ralf Dürr	18
6	Role of nonneutralizing antibodies in vaccines and/or HIV infected individuals 2017 ·Current Opinion in HIV and AIDS ·Luzia Mayr, Bin Su, Christiane Moog	12
7	Langerhans Cells: the ‘Yin and Yang’ of HIV Restriction and Transmission 2017 ·Trends in Microbiology ·Luzia Mayr, Bin Su, Christiane Moog	16
8	Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity 2017 ·Scientific Reports ·Luzia Mayr, Thomas Decoville, Sylvie Schmidt, Géraldine Laumond, Jéromine Klingler, (unknown), Seiamak Bahram, Susan Zolla‐Pazner, Christiane Moog	35
9	Non-Neutralizing Antibodies Directed against HIV and Their Functions 2017 ·Frontiers in Immunology ·Luzia Mayr, Bin Su, Christiane Moog	44
10	Short Communication: Exploring Antibody Potential as Prophylactic/Therapeutic Strategies for Prevention of Early Mucosal HIV-1 Infection 2015 ·AIDS Research and Human Retroviruses ·Bin Su, Maryse Peressin, (unknown), (unknown), Luzia Mayr, Géraldine Laumond, Sylvie Schmidt, Thomas Decoville, Christiane Moog	6
11	Antibodies Targeting the Envelope of HIV-1 2015 ·Microbiology Spectrum ·Luzia Mayr, Susan Zolla‐Pazner	8
12	Functional and Structural Characterization of Human V3-Specific Monoclonal Antibody 2424 with Neutralizing Activity against HIV-1 JRFL 2015 ·Journal of Virology ·Rajnish Kumar, Ruimin Pan, Chitra Upadhyay, Luzia Mayr, Sandra Cohen, Xiaohong Wang, Preetha Balasubramanian, Arthur Nádas, Michael S. Seaman, Susan Zolla‐Pazner, Miroslaw K. Górny, Xiang‐Peng Kong, Catarina E. Hioe	8
13	Distinct Mechanisms Regulate Exposure of Neutralizing Epitopes in the V2 and V3 Loops of HIV-1 Envelope 2014 ·Journal of Virology ·Chitra Upadhyay, Luzia Mayr, Jing Zhang, Rajnish Kumar, Miroslaw K. Górny, Arthur Nádas, Susan Zolla‐Pazner, Catarina E. Hioe	34
14	Epitope Mapping of Conformational V2-specific Anti-HIV Human Monoclonal Antibodies Reveals an Immunodominant Site in V2 2013 ·PLoS ONE ·Luzia Mayr, Sandra Cohen, Brett Spurrier, Xiang‐Peng Kong, Susan Zolla‐Pazner	37
15	The evolution of HIV‐1 group M genetic variability in Southern Cameroon is characterized by several emerging recombinant forms of CRF02_AG and viruses with drug resistance mutations 2013 ·Journal of Medical Virology ·Lucy Agyingi, Luzia Mayr, Thompson Kinge, (unknown), (unknown), (unknown), Mpoame Mbida, Indira Hewlett, Phillipe N. Nyambi	14
16	Superinfection by Discordant Subtypes of HIV-1 Does Not Enhance the Neutralizing Antibody Response against Autologous Virus 2012 ·PLoS ONE ·Luzia Mayr, Rebecca Powell, (unknown), (unknown), Arthur Nádas, Phillipe N. Nyambi	6
17	Genetic variability and drug resistance mutations in HIV-1 infected individuals on HAART or drug naïve in Limbe, Cameroon 2012 ·Retrovirology ·Lucy Agyingi, (unknown), Luzia Mayr, Thompson Kinge, Mpoame Mbida, Phillipe N. Nyambi	1
18	Sequence Analysis of the Dimerization Initiation Site of Concordant and Discordant Viral Variants Superinfecting HIV Type 1 Patients 2011 ·AIDS Research and Human Retroviruses ·Luzia Mayr, Rebecca Powell, Thompson Kinge, Phillipe N. Nyambi	1
19	Neuropilin-1 Expression on Regulatory T Cells Enhances Their Interactions with Dendritic Cells during Antigen Recognition 2008 ·Immunity ·Milka Sarris, Kristian G. Andersen, Felix Randow, Luzia Mayr, Alexander G. Betz	280
20	The B7 Homolog Butyrophilin BTN2A1 Is a Novel Ligand for DC-SIGN 2007 ·The Journal of Immunology ·Georg Malcherek, Luzia Mayr, Pedro Roda‐Navarro, David A. Rhodes, Nigel Miller, John Trowsdale	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact